I was interested to see they had already received $52,375 in "licence revenue" in respect of the hernia repair feasibility agreement in the last half.
Here's an interesting article on trials of another synthetic product for hernia repair (Gore BioA), which gives a good overview of available options and issues: http://www.goremedical.com/resources/dam/assets/AP2975-EN1.pdf